Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
FDA just approved first generic GLP-1 for #WeightLoss: Liraglutide (Saxenda)
These studies have similarly shown no significant increase in thyroid cancer rates compared to the general population
No calendar links
The post says the conversation with a provider should cover mechanism of action, meaning single versus dual receptor activity, clinical evidence in the patient's own population, cost and insurance coverage, dosing flexibility needs, and any contraindications or comorbidities
Lab and animal studies of GLP-1 patches Scientists are testing real GLP1 patches in the lab, but almost all of the research has been done in animals, not people
It appears to act as an exercise-responsive endocrine signal that enhances metabolic flexibility without directly suppressing appetite or altering central satiety circuits
